A 'New Generation' Stem Cell Transplant Significantly Reduces Complications for Patient (IMAGE)
Caption
In a Phase One-Two clinical trial, the great majority of patients with blood cancers are on the road to recovery, thanks to the UM171 molecule, discovered at the Institute for Research in Immunology and Cancer of the Université de Montréal by Guy Sauvageau and Anne Marinier.
Credit
IRIC.
Usage Restrictions
This photo can only be used with text about this clinical trial.
License
Licensed content